did they stop making tirzepatide Eli Lilly's is off the FDA's drug shortage list: Here's what it means Tirzepatide, a New Era of

Additionally, it signals your brain to reduce appetite and quiet food noise

You can read the abstract of this article at LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of concept A novel dual GIP and GLP-1 receptor agonist, LY3298176, was developed to determine whether the metabolic action of GIP adds to the established clinical benefits of selective GLP-1 receptor agonists in type 2 diabetes mellitus (T2DM)

Primarily approved for type 2 diabetes management, it's also sometimes prescribed off-label for weight management

Diec CB et al